 Shares of Indaptus Therapeutics Inc. INDP, 190.95 nearly tripled on massive volume in midday trading, to bounce off the previous sessions record closing low, after the developer of treatments for hepatitis and HIV announced the allowance of a patent for its platform technology. The stock was up as much as 307.8 at a six-month high of 28.83 before paring gains to be up 184.3. 